XML 23 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income (loss) $ 1,158,000 $ 1,056,000 $ 860,000
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used for) operating activities:      
Depreciation, amortization and accretion 1,644,000 1,608,000 1,572,000
(Gains) losses on retirement of long-term obligations [1] 145,000 95,000 2,000
Amortization of deferred financing costs and other non-cash interest, net 13,000 6,000 1,000
Stock-based compensation expense 129,000 138,000 117,000
Asset write-down charges 21,000 74,000 19,000
Deferred income tax (benefit) provision 4,000 3,000 2,000
Other non-cash adjustments, net 21,000 5,000 (2,000)
Changes in assets and liabilities, excluding the effects of acquisitions:      
Increase (decrease) in accrued interest (17,000) 31,000 21,000
Increase (decrease) in accounts payable 15,000 (77,000) 19,000
Increase (decrease) in other liabilities (118,000) (65,000) 254,000
Decrease (increase) in receivables (113,000) 166,000 (96,000)
Decrease (increase) in other assets (113,000) 15,000 (71,000)
Net cash provided by (used for) operating activities 2,789,000 3,055,000 2,698,000
Cash flows from investing activities:      
Capital expenditures 1,229,000 1,624,000 2,057,000
Payments for acquisitions, net of cash acquired 111,000 107,000 17,000
Other investing activities, net 8,000 (10,000) (7,000)
Net cash provided by (used for) investing activities (1,332,000) (1,741,000) (2,081,000)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 3,985,000 3,733,000 1,894,000
Principal payments on debt and other long-term obligations 1,076,000 105,000 86,000
Purchases and redemptions of long-term debt 2,089,000 2,490,000 12,000
Borrowings under revolving credit facility 1,245,000 2,430,000 2,110,000
Payments under revolving credit facility 870,000 2,665,000 2,660,000
Net issuances (repayments) under commercial paper program (20,000) 130,000 155,000
Payments for financing costs 42,000 38,000 24,000
Purchases of common stock 70,000 76,000 44,000
Dividends/distributions paid on common stock 2,373,000 2,105,000 1,912,000
Dividends/distributions paid on preferred stock 0 85,000 113,000
Net cash provided by (used for) financing activities (1,310,000) (1,271,000) (692,000)
Net increase (decrease) in cash, cash equivalents, and restricted cash from continuing operations 147,000 43,000 (75,000)
Cash Provided by (Used in) Operating Activities, Discontinued Operations (62,000) 0 0
Net Cash Provided by (Used in) Discontinued Operations (62,000) 0 0
Effect of exchange rate changes on cash 0 0 0
Cash, Cash Equivalents and Restricted Cash - Beginning of Period 381,000 338,000 413,000
Cash, Cash Equivalents and Restricted Cash - End of Period $ 466,000 $ 381,000 $ 338,000
[1] Inclusive of the write-off of the respective deferred financing costs.